Fobio
福贝生物
Fobio (福贝生物 / 4B Technologies) is a Chinese biotech company developing first-in-class drugs for central nervous system diseases, founded by neuroscientist and Tsinghua professor Lu Bai and former GSK R&D vice president Guan Xiaoming, who serves as co-founder and CEO . The company targets conditions including ALS, stroke, chronic pain, glaucoma, and Alzheimer's through a pipeline of nine programs spanning small molecules and biologics, with several candidates—such as the ALS drug FB-1071 and acute optic nerve injury treatment FB1001—having entered or nearing clinical trials as of late 2022 . Fobio has raised multiple rounds from investors including Gaorong Ventures, which led its A+ round in 2019 and continued to back its A++ and Pre-B rounds, with total funding reaching $25 million by early 2021 and over 100 million yuan in its December 2022 Pre-B round . The firm operates R&D and clinical centers in Suzhou and Beijing .
AI-generated — may contain errors, please verify.
Coverage
Rongbao | Hydrogen energy and battery management tech firms secure new funding; innovative drug targets precise efficacy
Grow, toward the future.
Accelerated R&D and Commercialization of Frontier Products: Medical Devices, Digital Services, and New Brands Go Global | Rongbao
As the year draws to a close and a new one begins, the pace never lets up.
Medical Device/Chip Companies Close New Funding Rounds, Driving High-Quality Growth Through R&D, Commercialization, and Supply Chain | Rong Report · February
Infinite possibilities for creating a better life.
BOSS Zhipin Completes Dual Primary Listing, Baijiayun Debuts on Nasdaq, Gaorong Ventures Earns Multiple Accolades | Gaorong Monthly · December
Racing Into 2023
From Big Pharma to Biotech: Four Industry Leaders on How Innovative Drugs Can Balance Speed and Quality | Ronghui
Speed matters, but getting it right matters more.
Robotics, SaaS, and innovative drug sectors close new funding rounds; chips and medical devices unveil major new products | Rongbao · August
Differentiated innovation and global opportunities.
Rongbao · February | Pinduoduo Awarded "National Advanced Collective in Poverty Alleviation," Chip and Medical Companies Complete New Funding Rounds
Pinduoduo contributes to poverty alleviation; XinYaohui, Fubei Biotech, and Westlake Omics close new funding rounds.
Fube Biotech Closes A++ Round to Pioneer CNS Drug R&D Through Homegrown Innovation
Accelerate multiple novel neurological drug candidates into clinical trials.
